{"id":218610,"date":"2025-07-24T04:21:09","date_gmt":"2025-07-24T09:21:09","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/07\/virtual-reality-therapy-reduces-voice-hallucinations-in-schizophrenia-trial"},"modified":"2025-07-24T04:21:09","modified_gmt":"2025-07-24T09:21:09","slug":"virtual-reality-therapy-reduces-voice-hallucinations-in-schizophrenia-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/07\/virtual-reality-therapy-reduces-voice-hallucinations-in-schizophrenia-trial","title":{"rendered":"Virtual reality therapy reduces voice hallucinations in schizophrenia trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/virtual-reality-therapy-reduces-voice-hallucinations-in-schizophrenia-trial.jpg\"><\/a><\/p>\n<p>Copenhagen University Hospital\u2019s VIRTU Research Group reports that an immersive virtual reality-assisted therapy called Challenge-VRT yielded a statistically significant, short-term reduction in auditory verbal hallucination severity among Danish adults with schizophrenia spectrum disorders.<\/p>\n<p>Auditory verbal hallucinations rank among the most frequent and distressing features of schizophrenia, affecting roughly 75% of patients and resisting medication in about one-third. Approximately 13% of patients experience worsening hallucinations during their first decade of illness.<\/p>\n<p>Current cognitive behavioral and relational psychotherapies show modest effects, leaving a clear unmet need for innovative treatment approaches.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Copenhagen University Hospital\u2019s VIRTU Research Group reports that an immersive virtual reality-assisted therapy called Challenge-VRT yielded a statistically significant, short-term reduction in auditory verbal hallucination severity among Danish adults with schizophrenia spectrum disorders. Auditory verbal hallucinations rank among the most frequent and distressing features of schizophrenia, affecting roughly 75% of patients and resisting medication in [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47,1879],"tags":[],"class_list":["post-218610","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience","category-virtual-reality"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/218610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=218610"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/218610\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=218610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=218610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=218610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}